Credential Securities’s GSK GSK Stock Holding History

Credential Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$250K	Sell	4,958 -165	-3%	-$8.31K	0.06%	154
2018 Q1	$250K	Buy	+5,123	New	+$239K	0.06%	154
2017 Q4	–	Sell	-7,346	Closed	-$373K	–	263
2017 Q3	$373K	Buy	7,346 +59	+0.8%	+$2.99K	0.1%	140
2017 Q2	$394K	Sell	7,287 -257	-3%	-$13.7K	0.12%	134
2017 Q1	$398K	Buy	7,544 +67	+0.9%	+$3.4K	0.14%	133
2016 Q4	$360K	Sell	7,477 -473	-6%	-$23.4K	0.14%	134
2016 Q3	$429K	Sell	7,950 -8	-0.1%	-$439	0.19%	123
2016 Q2	$431K	Buy	7,958 +3	+0%	+$158	0.22%	122
2016 Q1	$403K	Sell	7,955 -31	-0.4%	-$1.54K	0.23%	119
2015 Q4	$403K	Buy	7,986 +141	+2%	+$7.19K	0.26%	109
2015 Q3	$377K	Sell	7,845 -3,799	-33%	-$198K	0.26%	107
2015 Q2	$606K	Buy	11,644 +208	+2%	+$11.7K	0.38%	80
2015 Q1	$659K	Buy	11,436 +650	+6%	+$37.3K	0.43%	73
2014 Q4	$576K	Buy	10,786 +691	+7%	+$38.7K	0.37%	82
2014 Q3	$584K	Buy	10,095 +605	+6%	+$37.1K	0.39%	77
2014 Q2	$634K	Buy	9,490 +709	+8%	+$48K	0.42%	70
2014 Q1	$587K	Buy	+8,781	New	+$594K	0.44%	61

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Credential Securities's GSK Position: Q2 2018 in Review

Credential Securities reduced its GSK (GSK) stake by 3.2% in Q2 2018, selling an estimated $8.31K and leaving 4,958 shares worth $250K. The position accounts for 0.06% of the portfolio, ranked #154.

Credential Securities first reported a position in GSK in Q1 2014 and has held it in 17 quarters since. The position peaked at $659K in Q1 2015. 788 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

Credential Securities held 4,958 shares of GSK worth $250K as of Q2 2018.
Credential Securities sold 165 GSK shares in Q2 2018, an estimated $8.31K.
GSK made up 0.06% of Credential Securities's portfolio in Q2 2018, its #154 holding.
Credential Securities first reported a position in GSK in Q1 2014 and has held it in 17 quarters since.
Credential Securities's GSK position peaked at $659K in Q1 2015.
788 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.